Urinary tract infections (UTIs) encompass a large variety of clinical
conditions ranging from asymptomatic bacteriuria in healthy individual
s to life-threatening bacteraemic infections. The choice of antibiotic
therapy must be based on identification of the type of UTI to be trea
ted, possible contraindicating factors with the individual patient and
, above all, knowledge of the antibiotic resistance pattern in the geo
graphical area where the patient acquired the bacteriura. In many coun
tries trimethoprim-sulphonamide combinations, trimethoprim plain or ni
trofurantoin are still useful drugs. Generally, the clinical efficacy
of oral beta-lactams such as amoxicillin, ampicillin and cephalosporin
s seems to be less good than those of fluoroquinolones and the above-m
entioned antibiotics. However, too frequent use of quinolones may lead
to increased frequencies of resistance to those antibiotics in common
species such as Escherichia coli. It is therefore recommended not to
use fluoroquinolones in patients with sporadic uncomplicated cystitis,
i.e., the most common type of UTI, but to reserve the modern quinolon
es for patients with pyelonephritis, complicated UTI or recurrent UTI.